메뉴 건너뛰기
Current Oncology
Volumn 18, Issue 1, 2011, Pages 16-17
Weekly paclitaxel in ovarian cancer- the latest success story
Author keywords

Adjuvant chemotherapy; Intraperitoneal chemotherapy; Ovarian cancer; Weekly paclitaxel
Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;
EID: 79751472252     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (13)
References (8)
  • 1
    • 33646562149 scopus 로고    scopus 로고
    • 2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study
    • 2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study. Gynecol Oncol 2006; 101: 436-40.
    • (2006) Gynecol Oncol , vol.101 , pp. 436-440
    • Markman, M.1    Blessing, J.2    Rubin, S.C.3
  • 2
    • 70349878651 scopus 로고    scopus 로고
    • Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
    • On behalf of the Japanese Gynecologic Oncology Group
    • Katsumata N, Yasuda M, Takahashi F, et al. On behalf of the Japanese Gynecologic Oncology Group. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet 2009; 374:1331-8.
    • (2009) Lancet , vol.374 , pp. 1331-1338
    • Katsumata, N.1    Yasuda, M.2    Takahashi, F.3
  • 3
    • 42249083269 scopus 로고    scopus 로고
    • Weekly paclitaxel in the adjuvant treatment of breast cancer
    • Sparano JA, Wang M, Martino S, et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008; 358:1663-71.
    • (2008) N Engl J Med , vol.358 , pp. 1663-1671
    • Sparano, J.A.1    Wang, M.2    Martino, S.3
  • 4
    • 12344276384 scopus 로고    scopus 로고
    • A phase ii trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma
    • Rose PG, Smrekar M, Fusco N. A phase ii trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma. Gynecol Oncol 2005; 96:296-300.
    • (2005) Gynecol Oncol , vol.96 , pp. 296-300
    • Rose, P.G.1    Smrekar, M.2    Fusco, N.3
  • 5
    • 70349859988 scopus 로고    scopus 로고
    • Dose-dense chemotherapy in advanced ovarian cancer
    • Bookman MA. Dose-dense chemotherapy in advanced ovarian cancer. Lancet 2009; 374:1303-5.
    • (2009) Lancet , vol.374 , pp. 1303-1305
    • Bookman, M.A.1
  • 6
    • 30044438368 scopus 로고    scopus 로고
    • Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    • On behalf of the Gynecologic Oncology Group
    • Armstrong DK, Bundy B, Wenzel L, et al. On behalf of the Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354:34-43.
    • (2006) N Engl J Med , vol.354 , pp. 34-43
    • Armstrong, D.K.1    Bundy, B.2    Wenzel, L.3
  • 7
    • 34447560090 scopus 로고    scopus 로고
    • Intraperitoneal chemotherapy for ovarian cancer: Overview and perspective
    • Rao G, Crispens M, Rothenberg ML. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective. J Clin Oncol 2007; 25:2867-72.
    • (2007) J Clin Oncol , vol.25 , pp. 2867-2872
    • Rao, G.1    Crispens, M.2    Rothenberg, M.L.3
  • 8
    • 77950497098 scopus 로고    scopus 로고
    • Current drugs still have potential in advanced ovarian cancer
    • Hogberg T. Current drugs still have potential in advanced ovarian cancer. Nat Rev Clin Oncol 2010; 7:191-3.
    • (2010) Nat Rev Clin Oncol , vol.7 , pp. 191-193
    • Hogberg, T.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.